OREGA Biotech orega-biotech.com


OREGA Biotech specializes in the discovery and the development of first-in-class monoclonal antibodies for cancer immunotherapy. With a specific focus on tumor microenvironment, OREGA's Target Discovery Program aims at discovering and validating novel clinically-relevant cancer targets.

OREGA Biotech specializes in the discovery and the development of first-in-class monoclonal antibodies for cancer immunotherapy. With a specific focus on tumor microenvironment, OREGA's Target Discovery Program aims at discovering and validating nove...Show all

Company (Alive / Active)

Phone:

Fax:



Ecully,
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
OREGA Biotech $0M Dec 29, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related OREGA Biotech Jobs

jobs by Indeed job search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antagonists of il-17 isoforms and their uses Nov 20, 2017 Jul 16, 2019 Patent
Antagonists of il-17 isoforms and their uses Jun 11, 2013 Dec 05, 2017 Patent
Il-17 antagonist antibodies Jun 25, 2013 Jun 13, 2017 Patent
File management system and file management method Aug 20, 2012 Apr 26, 2016 Patent
Combinations therapies for the treatment of cancer May 09, 2017 Application
See all 9 patents